Back to results
US 2015/0030598 A1Published application
Tri- or tetraspecific antibodies
AssigneeHoffmann-La Roche Inc.
InventorsRebecca CROASDALE, Christian KLEIN, Wolfgang SCHAEFER, Juergen Michael SCHANZER
Life of this patent
Estimating the term…
Abstract
The present invention relates to tri- or tetraspecific antibodies, their manufacture and use.
Claims21
1-26. (canceled)
One or more nucleic acid molecules encoding a trispecific or tetraspecific antibody, wherein the antibody comprises:
- a) a light chain and heavy chain of a full length antibody which specifically binds to a first antigen;
- and
- b) a modified light chain and modified heavy chain of a full length antibody which specifically binds to a second antigen, wherein the variable domains VL and VH are replaced by each other, and/or wherein the constant domains CL and CH1 are replaced by each other;
- and
- c) one to four antigen binding peptides fused via a peptide connector to the C- or N-terminus of the light chains or heavy chains of a) and/or b) wherein said antigen binding peptides specifically bind one or two further antigens.
2 more elements
One or more nucleic acid molecules encoding a tetraspecific antibody, wherein the antibody comprises:
- a) a light chain comprising the amino acid sequence of SEQ ID NO:
- 1;
- b) a modified heavy chain comprising the amino acid sequence of SEQ ID NO:
- 2;
- c) a modified light chain comprising the amino acid sequence of SEQ ID NO:
- 3;
- and
- d) a modified heavy chain comprising the amino acid sequence of SEQ ID NO:
- 4.
6 more elements
Dependencies are inferred from the claim text.